Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Trial Phase 2 Completed Dec. 23, 2020

Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study

Trial N/A Not yet recruiting Dec. 23, 2020

Spinal Cord Stimulation Therapy for Freezing of Gait in Parkinson's Syndrome Patients

Trial N/A Unknown Dec. 23, 2020

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Shoulder Disorders in Patients With Parkinson's Disease

Trial N/A Completed Dec. 22, 2020

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Trial Phase 2 Completed Dec. 22, 2020

Vibration Impact on Parkinson's Tremor

Trial N/A Completed Dec. 16, 2020

Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain

Trial Early Phase 1 Completed Dec. 13, 2020

Oxford Study of Quantification in Parkinsonism

Trial N/A Unknown Dec. 10, 2020

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

Trial N/A Completed Dec. 8, 2020

Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)

Trial Phase 1 Terminated Dec. 8, 2020

PK Study in Patients With Parkinson's Disease With IZD174

Trial Phase 1 Withdrawn Dec. 3, 2020

Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease

Trial N/A Completed Dec. 2, 2020

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

Trial N/A Completed Dec. 1, 2020

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

Trial Phase 2 Completed Nov. 30, 2020

MER Versus MRI Guidance DBS in Parkinson's Disease

Trial N/A Completed Nov. 24, 2020

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Trial Phase 2 Terminated Nov. 22, 2020